• Molecular Imaging Probes: Discovery, Development and Manufacturing

    Molecular Imaging Probes: Discovery, Development and Manufacturing

    Taking novel imaging probes from discovery in a lab setting, through full development and on to manufacturing and clinical trials is one of the goals of the MITNEC program and the Centre for Probe Development and Commercialization. Dr. Valliant, the leader of the CPDC and a collaborator in MITNEC outlines each stage in this process, describing all of the steps involved. In particular, new probes in development for imaging neurologic disease are discussed.

    Read More
  • Ultrasound Techniques for Carotid Imaging: 3D Ultrasound

    Ultrasound Techniques for Carotid Imaging: 3D Ultrasound

    Using specialized equipment and advanced software, Dr. Fenster et al. have extended 2 dimensional ultrasound images to 3 dimensional acquisition. Through further software development, it has been possible for his team to reconstruct and measure existing carotid plaque in real time, allowing for accurate mapping of plaque regression or progression over time. Looking forward, Dr. Fenster describes current programs attempting to semi-automate plaque tracing on images.

    Read More
  • PET Agents in Clinical Oncology: Role of Radiopharmaceutical Science

    PET Agents in Clinical Oncology: Role of Radiopharmaceutical Science

    In keeping with the goals of the MITNEC program, Dr. Mercer discusses the roles of radiopharmaceuticals in PET and SPECT imaging. Flourine-based FDG is by far the most common of the imaging probes and is suitable for most cases, but it is not appropriate for all types of cancer. Other imaging probes have been developed for specific purposes and new probes are being investigated for enhanced pathology differentiation. The process of novel radiopharmaceutical development is discussed, together with case studies of Edmonton-based developments and current trends in research.

    Read More
  • 1
  • 2
  • 3
  • Overview of Medical Imaging in Oncology +

    Overview of Medical Imaging in Oncology Positron Emission Tomography is an invaluable and perhaps most important tool for assessing cancer in vivo. Dr. Burrell provides a Read More
  • Molecular Imaging Probes: Discovery, Development and Manufacturing +

    Molecular Imaging Probes: Discovery, Development and Manufacturing Taking novel imaging probes from discovery in a lab setting, through full development and on to manufacturing and clinical trials Read More
  • Measuring Tissue Perfusion with Magnetic Resonance +

    Measuring Tissue Perfusion with Magnetic Resonance The ability to calculate tissue perfusion accurately is clinically important challenge. Using magnetic resonance imaging, Dr. Frayne discusses two approaches Read More
  • CT Measurement of Myocardial Perfusion +

    CT Measurement of Myocardial Perfusion The ability to determine the functional significance of coronary stenosis and myocardium at risk in the clinical emergency setting is Read More
  • Imaging Biomarkers in Vascular Cognitive Impairment +

    Imaging Biomarkers in Vascular Cognitive Impairment Using imaging to help unravel the complex relationships between vascular disease and cognitive impairment is the outline for this presentation. Read More
  • 1
  • 2